NurExone Biologic Inc.
NRX.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.14M | 983.00K | 1.23M | 588.00K | 700.00K |
| Total Receivables | 89.00K | 122.00K | 84.00K | 135.00K | 127.00K |
| Inventory | -- | -- | 600.00K | 600.00K | 600.00K |
| Prepaid Expenses | 95.00K | -- | -- | -- | 166.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 279.00K | 41.00K | 41.00K | 41.00K | 41.00K |
| Total Current Assets | 2.60M | 1.15M | 1.95M | 1.36M | 1.63M |
|
|
|||||
| Total Current Assets | 2.60M | 1.15M | 1.95M | 1.36M | 1.63M |
| Net Property, Plant & Equipment | 864.00K | 882.00K | 911.00K | 776.00K | 807.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 618.00K | 618.00K | -- | -- | -- |
| Total Assets | 4.08M | 2.65M | 2.86M | 2.14M | 2.44M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 690.00K | 366.00K | 329.00K | 187.00K | 339.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 38.00K | -- | -- | -- | 2.00K |
| Total Finance Division Other Current Liabilities | 261.00K | 496.00K | 678.00K | 366.00K | 57.00K |
| Total Other Current Liabilities | 261.00K | 496.00K | 678.00K | 366.00K | 57.00K |
| Total Current Liabilities | 989.00K | 862.00K | 1.01M | 553.00K | 398.00K |
|
|
|||||
| Total Current Liabilities | 989.00K | 862.00K | 1.01M | 553.00K | 398.00K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 70.00K | 79.00K | 91.00K | 31.00K | 31.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 266.00K | 248.00K | 234.00K | 240.00K | 251.00K |
| Total Liabilities | 1.33M | 1.19M | 1.33M | 824.00K | 680.00K |
|
|
|||||
| Common Stock & APIC | 26.09M | 23.82M | 22.75M | 20.41M | 19.47M |
| Retained Earnings | -25.48M | -24.09M | -22.62M | -20.78M | -19.10M |
| Treasury Stock & Other | 2.15M | 1.72M | 1.40M | 1.68M | 1.40M |
| Total Common Equity | 2.76M | 1.46M | 1.53M | 1.32M | 1.76M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.76M | 1.46M | 1.53M | 1.32M | 1.76M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.76M | 1.46M | 1.53M | 1.32M | 1.76M |
|
|
|||||